Real-time enrollment status for this solid tumors (phase 1) clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 2:33 PM UTC
| NCT Number | NCT07252479 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumors (Phase 1) |
| Phase | PHASE1 |
| Target Enrollment | 118 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Adlai Nortye Biopharma Co., Ltd. |
| Last Updated on CT.gov | June 8, 2026 (Jun 8, 2026) |
As of September 1, 2026: Clinical trial NCT07252479 is currently recruiting participants. This phase1 study for solid tumors (phase 1) is actively seeking new participants at 3 locations across the United States. The study is sponsored by Adlai Nortye Biopharma Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07252479 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07252479 was last updated Jun 8, 2026 (June 8, 2026). HelloStudys verifies this status automatically.